NCT01953822 2016-12-26Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United KingdomGlaxoSmithKlineCompleted1,053 enrolled
NCT01153906 2014-12-02Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® VaccinationGlaxoSmithKlineCompleted1,516 enrolled